Trials / Completed
CompletedNCT03006536
Low-Intensity Extracorporeal Shock Wave Treatment for Erectile Dysfunction: A Randomized, Controlled, Double Blind Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Zealand University Hospital · Academic / Other
- Sex
- Male
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The proposed mechanism of action for LI-ESWT in ED is that it improves endothelial function and triggers angiogenesis through induction of local growth factors and endothelial nitric oxide synthase. The literature generally confirms that LI-ESWT is safe and cohort studies investigating the clinical effects have been encouraging. Meanwhile, randomized trials have shown contradictory results. Thus, a randomized trial in 67 PDE5-I responders showed statistically greater improvements in the Erectile Function Domain of the International Index of Erectile Function (IIEF) with active LI-ESWT treatment compared to a sham treatment (p=0.032).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Li-ESWT | Participants will undergo 6 treatment sessions 2/week with 1 week pause with the Duolith® SD1 machine (Storz, Tägerwilen, Switzerland) according to the company's instructions |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2022-03-13
- Completion
- 2022-03-13
- First posted
- 2016-12-30
- Last updated
- 2024-01-30
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03006536. Inclusion in this directory is not an endorsement.